“…Patients with the mentioned neurological diseases showed significantly increased (with respect to controls) plasma levels of TBARS (24, 20, and 19%, respectively), significantly decreased plasma TRAP capacity (32,25, and 28%, respectively) and significantly increased SOD activity in red blood cells (73, 63, and 55%, respectively) with unchanged erythrocyte CAT and GPx activities ( Table 1). The differences in plasma TBARS and TRAP levels and in erythrocyte SOD between the control healthy subjects and the neurological patients with either Alzheimer's disease, vascular dementia or Parkinson disease are highly significant, specially after considering that [35][36][37] and TRAP [38,39]; and for erythrocyte SOD [36][37][38][40][41][42], CAT [36,37,42,43] and GPx activities [36,37,43,44].…”